Sun Pharma, Cipla, Zydus, Graviti recall drugs in U.S. market
Drugmakers Sun Pharma, Cipla, Zydus and Graviti Pharmaceuticals are recalling different products in the U.S., most of them over manufacturing issues, according to latest U.S FDA enforcement reports. Sun Pharma…
16 states and 6 UTs did not submit NSQ data in December to CDSCO
New Delhi: Even as the drug regulators in the country have announced a total of 167 drug samples tested during the month of December as Not of Standard Quality (NSQ),…
Maha to manufacture goatpox vaccine at its Pune institute
PUNE: The Maharashtra animal husbandry department will begin manufacturing goatpox vaccine at its Pune-based Institute of Veterinary Biological Products (IVBP), making it the first government-run institute in India to develop…
Unnecessary use of steroid leads to risk of severe fungal infections: Doctors
Pune: After the use of steroids for routine viral fevers and mild respiratory infections has grown among people, doctors in the city warned that it could increase the risk of…
Spurious cosmetic packaging factory busted in northwest Delhi
New Delhi: In a significant breakthrough under ‘Operation Kavach,’ the Cyber Cell of the Crime Branch, Delhi, has unearthed a major illegal manufacturing unit involved in the fabrication of empty…
Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers
The Bombay High Court (Nagpur Bench) last week expressed serious concern over repeated and systemic lapses by officers of the Drugs Department in adhering to the mandatory timelines prescribed under…
UP plans US FDA-accredited medical device testing lab
Lucknow: In a major push to strengthen India’s medical device and pharmaceutical manufacturing ecosystem, the Uttar Pradesh govt is working on an ambitious project to establish a US FDA-accredited medical…
Patent rejected for MNC’s cancer drug, generics to follow
NEW DELHI: In what could be good news for patients, Indian Patent Office (IPO) has rejected MNC AbbVie’s patent application for its blockbuster cancer drug Venetoclax citing lack of inventive…
Zydus brings world’s first Nivolumab biosimilar to India
Zydus Lifesciences Limited announced that it has launched the world’s first biosimilar of the cancer immunotherapy drug Nivolumab in India. This marks a major step toward improving access to advanced…
Dr Reddy’s set to start selling generic Ozempic in India at potentially half price
The prices of Ozempic in India can potentially halve to ₹3,600 after Dr. Reddy’s and its ilk start producing the generic version of semaglutide, Nomura says. Dr Reddy’s Laboratories Ltd. is…
